A comprehensive review of mechanisms, efficacy and clinical implica tions of UFH and LMWH in anticoagulant therapy: A prospective oncotarget
prevention of the thromboembolic disorders, with Unfractionated Heparin (UFH) and Low Molecular Weight Heparins (LMWH) being widely used agents due to their potential and anticancer properties. However, while both employ

